10/12/2026
Biologic Pharmamedical Wins 2026 Industry Innovation Award at White & Private Label Expo New York Research-driven nutraceutical company recognized for an innovation model that brings pharmaceutical-level scientific rigor to natural health.
NEW YORK, September 30, 2026 — Biologic Pharmamedical has been named the recipient of the 2026 Industry Innovation Award at the White & Private Label Expo in New York, recognizing the company’s approach to research, intellectual property and the development of next-generation natural health technologies.
The award was presented following Biologic’s presentation, “Where Pharmacology Meets Nature,” which explored a fundamental challenge within the nutraceutical industry: natural ingredients can vary considerably in their chemical composition, yet biological activity ultimately depends upon the specific compounds contained within them.
“This award means far more to us than recognition of a single product,” said Christina Weizmann, President & COO of Biologic Pharmamedical, who accepted the award in New York. “It recognizes a philosophy that Franco has spent years building—that natural health products deserve the same scientific curiosity, precision and rigor we expect in pharmaceutical research.”
Weizmann added:
“Plants are extraordinarily complex. Two extracts carrying the same ingredient name can have very different chemical compositions and therefore potentially very different biological effects. Our work is about understanding those differences, identifying what is actually driving the activity and then engineering technologies that can deliver that activity consistently.”
https://lnkd.in/g6hPxVF2